Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to C2orf88" (ENSG00000300493) refers to an uncharacterized RNA transcript that is transcribed from the DNA strand opposite to the gene C2orf88. C2orf88 itself is an open reading frame on chromosome 2 with minimal functional investigation, and the antisense transcript may represent a predicted or experimental non-coding RNA with unknown function. There is no published evidence to support a role for this transcript as a receptor, enzyme, or target for drugs, nor any established biological or medical relevance. Entries like this are found in genomic annotations and often await detailed functional study[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on novel transcript, antisense to C2orf88 (ENSG00000300493).